Joakim Wijkstrom - 18 Feb 2026 Form 4 Insider Report for Vanda Pharmaceuticals Inc. (VNDA)

Role: SVP, Chief Marketing Officer
Signature: /s/ Joakim Wijkstrom
Issuer symbol: VNDA
Transactions as of: 18 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 19 Feb 2026, 17:53:58 UTC
Previous filing: 04 Mar 2025
Next filing: 04 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Wijkstrom Joakim	SVP, Chief Marketing Officer	2200 PENNSYLVANIA AVENUE NW, SUITE 300E, WASHINGTON	/s/ Joakim Wijkstrom	19 Feb 2026	0001785888

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VNDA	Common Stock	Award	$0	+125,000	+52%	$0.000000	364,269	18 Feb 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2027, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.

Content

Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2027, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.